UltraTech Cement has reported strong volume growth of ~11% YoY versus the estimated industry volume growth of ~5% in Q3 FY25. There are signs of recovery in cement demand across all sectors including infrastructure, IHB, rural, and urban demand.
NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Motilal Oswal Report
UltraTech Cement Ltd.’s Q3 FY25 operating performance was in line with our estimate, with Ebitda standing at Rs 28.9 billion (declined 11% YoY). Ebitda/tonne stood at Rs 951 (-20% YoY; versus estimate Rs 925). Operating profit margin contracted 2.7pp YoY to ~17% (est. ~16%). Adjusted PAT declined ~17% YoY to Rs 14.7 billion (+14% vs. our estimate, led by higher other income and lower effective tax rate).
Management highlighted that its domestic grey cement capacity is expected to increase to ~185 mtpa by end-FY25 (including India Cements and Kesoram). The company is expected to post double-digit volume growth in FY26 vs industry growth at ~6-7% YoY.
The capacity utilization is estimated at ~80-85% on expanded capacity in FY26. With the acquisition of India Cements and Kesoram, the company’s capacity share is likely to increase to ~30% in the South region. It believes both assets (India Cements and Kesoram) have scope for improvement in capacity utilization.
We have incorporated India Cements in the company’s consolidated earnings estimates from Q4 FY25 and Kesoram cement assets from FY26E. The stock trades at 20x/16x FY26E/FY27E EV/Ebitda. We value UltraTech at 20 times FY27E EV/Ebitda and arrive at a target price of Rs 13,800. Reiterate Buy.
Click on the attachment to read the full report:
DISCLAIMER
This report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
RECOMMENDED FOR YOU

'Buy' Godrej Consumer Shares Maintains Motilal Oswal — Check Target Price


Ambuja Cement Q1 Review — Motilal Oswal Maintains 'Buy' On Above Estimate Results

UltraTech Cement Lines Up Rs 10,000 Crore Capex For FY26 To Bolster Capacity


UltraTech Cement Q1 Results Review: Motilal Oswal Maintains 'Buy' Post Inline Earnings
